Related references
Note: Only part of the references are listed.Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice
Chen-Feng Qi et al.
JOURNAL OF PATHOLOGY (2010)
Regulation and functional role of eEF1A2 in pancreatic carcinoma
Haixia Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
NOTCH Is Part of the Transcriptional Network Regulating Cell Growth and Survival in Mouse Plasmacytomas
Dong-Mi Shin et al.
CANCER RESEARCH (2008)
A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules
Ganna Panasyuk et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas
Yu Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein
Tatsuo Kido et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Eukaryotic elongation factor 1A2 cooperates with phosphatidylinositol-4 kinase III β to stimulate production of filopodia through increased phosphatidylinositol-4,5 bisphosphate generation
Sujeeve Jeganathan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade
G. Grassi et al.
BIOCHIMIE (2007)
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia
Eun Sung Park et al.
BMC GENOMICS (2007)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas:: overexpression of the gene is not dependent on modifications at the EEF1A2 locus
V. A. L. Tomlinson et al.
BRITISH JOURNAL OF CANCER (2007)
eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration
A. Amiri et al.
ONCOGENE (2007)
Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: Relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells
Chen-Feng Qi et al.
CANCER RESEARCH (2007)
Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer
Geeta Kulkarni et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress
Ruying Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Binding of elongation factor eEF1A2 to phosphatidylinositol 4-kinase β stimulates lipid kinase activity and phosphatidylinositol 4-phosphate generation
Sujeeve Jeganathan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The JAK-STAT pathway: A therapeutic target in hematological malignancies
A. Ferrajoli et al.
CURRENT CANCER DRUG TARGETS (2006)
Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach
R Li et al.
ONCOGENE (2006)
RNA-mediated response to heat shock in mammalian cells
I Shamovsky et al.
NATURE (2006)
Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas
CF Qi et al.
LEUKEMIA RESEARCH (2006)
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein
CH Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2 '-deoxycytidine treatment and oligonucleotide microarray
S Yamashita et al.
CANCER SCIENCE (2006)
Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours
VAL Tomlinson et al.
BMC CANCER (2005)
Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology
SR Gross et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A
SM Chuang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl
JQ Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis
S Akilesh et al.
GENOME RESEARCH (2003)
Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma -: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events
L Quintanilla-Martinez et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Regulation of peptide-chain elongation in mammalian cells
GJ Browne et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis
LB Ruest et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Moonlighting functions of polypeptide elongation factor 1: From actin bundling to zinc finger protein R1-associated nuclear localization
S Ejiri
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Combined histiologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice
HC Morse et al.
LEUKEMIA RESEARCH (2001)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
